IE 11 is not supported. For an optimal experience visit our site on another browser.

Low levels of chemical that’s been linked to cancer discovered in Zantac


The FDA issued an alert that Zantac and its generic versions contain low levels of a probable human carcinogen called NDMA, but it is not calling for individuals to stop taking the drug as the agency continues to investigate.